Suchergebnisse - "Gaba, Prakriti"

PubPharm (68)

1

Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Left Main Disease With and Without Diabetes : Findings From a Pooled Analysis of 4 Randomized Clinical Trials

enthalten in: Circulation | 2024

von Gaba, P. | Sabik, J. | Murphy, S. | +13

CommentIn: Circulation. 2024 Apr 23;149(17):1339-1340. - PMID 38648275

2

Influenza vaccination and use of lipid lowering therapies in adults with atherosclerotic cardiovascular disease : An analysis of the Behavioral Risk Factor Surveillance System (BRFSS)

enthalten in: American heart journal | 2024

von Slavin, S. | Berman, A. | Gaba, P. | +2

3

Icosapent ethyl for hypertriglyceridaemia and atherosclerosis : greater RESPECT for increased therapeutic use

enthalten in: European heart journal | 2024

von Gaba, P. | Bhatt, D. | Boden, W.

4

Promise of a Novel Classification System for Acute Myocardial Infarction

enthalten in: The Canadian journal of cardiology | 2024

von Gaba, P. | Bhatt, D.

CommentOn: Can J Cardiol. 2024 Jan;40(1):1-14. - PMID 37906238

5

Percutaneous Coronary Intervention vs Coronary Artery Bypass Graft Surgery for Left Main Disease in Patients With and Without Acute Coronary Syndromes : A Pooled Analysis of 4 Randomized Clinical Trials

enthalten in: JAMA cardiology | 2023

von Gaba, P. | Christiansen, E. | Nielsen, P. | +12

6

Association Between Achieved Low-Density Lipoprotein Cholesterol Levels and Long-Term Cardiovascular and Safety Outcomes : An Analysis of FOURIER-OLE

enthalten in: Circulation | 2023

von Gaba, P. | O'Donoghue, M. | Park, J. | +20

7

Evolving concepts of the vulnerable atherosclerotic plaque and the vulnerable patient : implications for patient care and future research

enthalten in: Nature reviews. Cardiology | 2023

von Gaba, P. | Gersh, B. | Muller, J. | +2

8

Comparison of Investigator-Reported vs Centrally Adjudicated Major Adverse Cardiac Events : A Secondary Analysis of the COMPASS Trial

enthalten in: JAMA network open | 2022

von Gaba, P. | Bhatt, D. | Dagenais, G. | +59

9

Benefits of icosapent ethyl for enhancing residual cardiovascular risk reduction : A review of key findings from REDUCE-IT

enthalten in: Journal of clinical lipidology | 2022

von Gaba, P. | Bhatt, D. | Mason, R. | +5

10

Prevention of Cardiovascular Events and Mortality With Icosapent Ethyl in Patients With Prior Myocardial Infarction

enthalten in: Journal of the American College of Cardiology | 2022

von Gaba, P. | Bhatt, D. | Steg, P. | +14

CommentIn: J Am Coll Cardiol. 2022 May 3;79(17):1672-1674. - PMID 35483754

1
2
3
4
5
6
7
Nächster »
[7]